Moderna ($MRNA) stock jumped 17% on Thursday, fueled by speculation of potential buyout talks amid concerns over declining ...
Zacks Investment Research on MSN
Earnings Preview: Moderna (MRNA) Q3 Earnings Expected to Decline
The market expects Moderna (MRNA) to deliver a year-over-year decline in earnings on lower revenues when it reports results ...
The biotech's innovative qualities will come in handy. Long gone are the days when Moderna ( MRNA 2.66%) would generate over $18 billion in annual sales from its COVID-19 vaccine. Over the past couple ...
Moderna, Inc. remains under pressure in 2025, despite recent next-gen COVID vaccine approval & cancer vaccine trial. Learn ...
Moderna Inc (NASDAQ:MRNA) stock is trading higher Wednesday afternoon, lifted by positive sentiment across the pharmaceutical sector. The rally follows a landmark agreement Tuesday between Pfizer Inc ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback